(42 days)
None
No
The document explicitly states "Mentions AI, DNN, or ML: Not Found" and the description focuses on standard image review and visualization tools.
No
The device is described as a web-based software for medical professionals to review medical images and dose distribution for planning purposes, but it explicitly states "It is not intended for the ... treatment of patients."
No
Explanation: The device is explicitly stated to not be intended for diagnosis ("It is not intended for the review of mammographic images, detailed treatment planning, plan approval or treatment of patients."). Instead, it is a tool for secure online image review for medical professionals with functions related to dose distribution information, primarily for radiotherapy treatment plan review, not primary diagnosis.
Yes
The device is described as "web based software" and "a software platform consisting of a set of server-based components". The description focuses entirely on software functionalities and integrations, with no mention of accompanying hardware components that are part of the medical device itself.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that Quentry Dose Review is for the review of medical images (DICOM and DICOM RT) and dose information by medical professionals. It is explicitly not intended for detailed treatment planning, plan approval, or treatment of patients. IVDs are used to examine specimens derived from the human body to provide information for diagnosis, monitoring, or screening. This device does not perform such examinations on biological samples.
- Device Description: The description focuses on the software's capabilities for visualizing and managing medical image data and dose information. It's part of a platform for sharing and discussing medical image data. This aligns with medical image viewing and management, not in vitro diagnostics.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, performing tests on bodily fluids or tissues, or providing diagnostic information based on such analyses.
The device is a medical image viewing and review software, specifically tailored for radiotherapy dose review, which falls under the category of medical devices, but not IVDs. The predicate devices listed (Advanced Viewer, iPlan RT) are also medical image viewing and planning systems, further supporting this conclusion.
N/A
Intended Use / Indications for Use
Quentry Dose Review is a web based software for medical professionals that provides doctors, physicians with tools for secure online image (DICOM RT) review including measurement and RT specific functions. such as display of dose distribution information, isodose lines, and dose volume histograms (DVH),
It is not intended for the review of mammographic images, detailed treatment planning, plan approval or treatment of patients. It is also not intended to be used on mobile systems.
For radiotherapy treatment plan approval, it is required to use the hospital specific workflows, tools and record&verify systems.
Product codes
LLZ, MUJ
Device Description
Quentry Dose Review is part of the online collaboration platform Quentry to share, discuss and transfer medical image data. The viewer provides capabilities to visualize medical images (DICOM and DICOM RT) and dose information.
Mentions image processing
system, image processing, radiological
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
DICOM images, DICOM RT images
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
medical professionals such as doctors, their assistants or nursing staff, within a clinic or at a doctor's office, or even at home.
The intended users are Physicians, Radiologists, Radio oncologists or their assistants.
The system can be used in a hospital environment, in a doctor's office, at home or any place with internet access.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The verification of the system Quentry Dose Review has been carried out thoroughly both at the top level and on the underlying subsystems. The verification was done to demonstrate that the design specifications are met.
The validation contained usability tests which should ensure that workflows or user interface result in a useful interface.
All test reports were finally rated as successful according to their acceptance criteria.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
JUN 2 0 2014
.
510 (K) SUMMARY QUENTRY DOSE REVIEW
・
IN ACCORDANCE WITH REQUIREMENTS OF 21 CFR PART 807.92
| Manufacturer: | Brainlab AG
Kapellenstrasse 12
85622 Feldkirchen
Germany |
|--------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Phone: +49 89 99 15 68 0
Fax: +49 89 99 15 68 33 |
| Submitter: | Rainer Birkenbach |
| Contact person: | Alexander Schwiersch |
| Summary date: | 4/30/2014 |
| Device: | QUENTRY DOSE REVIEW |
| Trade name: | QUENTRY DOSE REVIEW |
| Common/Classification
Name: | Picture archiving and communications system
System,Planning,Radiation Therapy Treatment |
| Main Predicate Device: | Advanced Viewer (K132763) |
| Secondary Predicate
Device: | iPlan RT (K103246) |
| Device classification
name: | system, image processing, radiological |
| Regulatory Class: | Class II |
| Regulation Number: | 892.2050, 892.5050 |
| Product Code: | LLZ, MUJ |
| Intended use: | Quentry Dose Review is a web based software for medical professionals that
provides doctors, physicists and physicians with tools for secure online image
(DICOM and DICOM RT) review including measurement and RT specific
functions, such as display of dose distribution information, isodose lines, and
dose volume histograms (DVH).
It is not intended for the review of mammographic images, detailed treatment
planning, plan approval or treatment of patients. It is also not intended to be
used on mobile systems.
For radiotherapy treatment plan approval, it is required to use the hospital
specific workflows, tools and record&verify systems. |
| Device description: | Quentry Dose Review is part of the online collaboration platform Quentry to
share, discuss and transfer medical image data. The viewer provides
capabilities to visualize medical images (DICOM and DICOM RT) and dose
information. |
REVISION 1
1
Quentry is a software platform consisting of a set of server-based components providing functions for transfer and storage of medical data, as well as user access via a web-based portal for data management, sharing, and download. The platform is integrated with desktop and server-based applications for upload and download of medical data from workstations and network-based image archive servers. The platform also provides interfaces for integration of third-party systems and applications. Quentry platform is an FDA class I product.
The device is generally used by medical professionals such as doctors, their assistants or nursing staff, within a clinic or at a doctor's office, or even at home.
Quentry Dose Review is a pure web application that is embedded in the Quentry web portal which is accessible from any computer with an appropriate internet connection.
Operator Profile
The intended users are Physicians, Radiologists, Radio oncologists or their assistants. Typical use cases of the embedded viewer together with the functionality of the web portal are:
- Physicians asking/providing colleagues for/with 2nd opinion .
- Radiologists comparing two RT plans for better patient treatment results
- . Physicians refer patients to other hospitals and send pictures and/or RT plans upfront
- Expert service: Several hospitals share one radiology department
Patient Population
There are no demographic, regional or cultural limitations for patients. It is up to the user to decide if the system shall be used to assist a certain procedure.
Conditions of use
The system can be used in a hospital environment, in a doctor's office, at home or any place with internet access.
2
Device Features:
Quentry Dose Review provides the following functions
| Feature | Detail |
|---|---|
| Load and import DICOM images | Load DICOM images from cloud database |
| View DICOM images | Viewer converts DICOM images to PNG format for viewing |
| Adjustment (pan, zoom, window, color scheme adjustment) | Review patient data with various adjustment |
| Reconstruction | Review patient data from different orientation |
| Measurement - distance | Viewer provides distance measurement between two arbitrary points |
| Measurement - point | Viewer provides gray level and dose value measurement for an arbitrary point |
| Voxel object | Review imported DICOM objects |
| Fused images | Review aligned patient data, e.g. CT, PT and so on |
| Cine loop playing | Display multiframe DICOM images |
| RT plan | Load RT plan |
| RT plan information | |
| RT plan comparison | |
| DVH comparison | |
| Review dose distribution | Dose distribution view |
| Dose analysis view | |
| DVH (PTVs & OARs) | |
| Manual input of normalization value |
Substantial equivalence:
Both Quentry Dose Review and Advanced Viewer are cloud-based software for viewing and manipulating DICOM images. Both of the proposed and predicate devices are to be used with any computer with appropriate internet connection. Equivalent with the predicate device, Quentry Dose Review is software installed in a web server that will communicate with the client via internet connection. Both devices utilize encrypted browser communication and provide image viewing and manipulation. However Quentry Dose Review enables DICOM RT images viewing functions, which Advanced Viewer does not provide.
iPlan RT is a radiation treatment planning system. This system generates treatment plans and simulates the dose delivery for external beam radiotherapy. One common function of iPlan RT and Quentry Dose Review is to review DICOM RT images. Quentry Dose Review and iPlan RT provide equivalent functions in viewing DICOM RT images. Equivalent to the predicate device, Quentry Dose Review is intended for medical professionals to review DICOM RT plans.
Conclusion:
Quentry Dose Review and Advanced Viewer have identical functionalities in DICOM viewing and identical technical characteristic. Quentry Dose Review is in addition capable of reviewing DICOM RT images. The RT functionalities are equivalent to these of iPlan RT.
FORM 04-195
REVISION 1
3
Quentry Dose Review has similar functionality, intended use, technological characteristics, and typical users as the predicate devices. Hence Quentry Dose Review does not introduce any new issues concerning safety and effectiveness, and is substantially equivalent to the predicate devices.
Verification/validation Verification summary:
The verification of the system Quentry Dose Review has been carried out thoroughly both at the top level and on the underlying subsystems. The verification was done to demonstrate that the design specifications are met.
Non-clinical validation
The validation contained usability tests which should ensure that workflows or user interface result in a useful interface.
All test reports were finally rated as successful according to their acceptance criteria. The non-clinical validation has been performed with software and units that are considered equivalent to the final version of the product, as warranted by 21 CFR 820.30 (g) and which have the UI as planned for the release.
The user tests were done in combination with the Quentry.com Portal which is developed and released by Voyant Health, a Brainlab company. The Quentry Dose Review workflow included also patient selection as interface between Quentry.com Portal and Quentry Dose Review.
Intended operational Environment
Standard computer with internet connection and mouse.
Operating System
The following versions or higher:
- Windows XP .
- Mac OS X 10 .
Browser
The following 32 bit versions or higher:
- Internet Explorer 8 ◆
- · · FireFox 3.x
- . Chrome 10
- . Safari 5
Microsoft® Silverlight® Plugin needed
Hardware
- 2GB RAM recommended .
- . Screen resolution: 1024x768 or higher
- . Mouse with scroll wheel recommended
Network
- Internet connection with at least 2 Mbit/sec. The internet connection must be stable. You may need to restart the viewer if the internet connection is unstable.
- Firewall with open outbound port 80/443 (http and https)
Known Exceptions
FORM 04-195
REVISION 1
4
K141199
Page 5 of 5
64 bit browsers are not supported by Microsoft® Silverlight®
and the comments of the comments of the comments of : . and the control control of the control of . . .
.
.
.
and the comments of the comments of the comments of the comments of the contraction of the contribution of the contribution of the contribution of the contribution of the con .
form 04-195
.
REVISION 1
PAGE 5 OF 5
5
Image /page/5/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines representing its wings, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged in a circle around the eagle. The text is in all caps and appears to be a sans-serif font. The logo is black and white.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Contral Center - WO66-Go(1) Silver Spring, MD 20993-0002
June 20, 2014
Brainlab AG % Mr. Alexander Schwiersch Regulatory Allairs Manager Kapellenstrasse 12 Feldkirchen 85622 GERMANY
Re: K141199 Trade/Device Name: Quentry Dose Review Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: May 12, 2014 Received: May 14, 2014
Dear Mr. Schwiersch:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading,
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
6
Page 2-Mr. Schwiersch
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
for
Janine M. Morris Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
7
Indications for Use
510(k) Number (if known)
Device Name Quentry Dose Review
Indications for Use (Describe)
Quentry Dose Review is a web based software for medical professionals that provides doctors, physicians with tools for secure online image (DICOM RT) review including measurement and RT specific functions. such as display of dose distribution information, isodose lines, and dose volume histograms (DVH),
It is not intended for the review of mammographic images, detailed treatment planning, plan approval or treatment of patients. It is also not intended to be used on mobile systems.
For radiotherapy treatment plan approval, it is required to use the hospital specific workflows, tools and record&verify systems.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signalure)
Smh. 7)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW."
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@lda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."